News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
679,671 Results
Type
Article (38856)
Company Profile (254)
Press Release (640561)
Section
Business (203715)
Career Advice (1981)
Deals (35370)
Drug Delivery (78)
Drug Development (80701)
Employer Resources (167)
FDA (16021)
Job Trends (14794)
News (344009)
Policy (32428)
Tag
Academia (2529)
Africa (711)
Alliances (49045)
Alzheimer's disease (1146)
Approvals (15944)
Arizona (174)
Artificial intelligence (69)
Asia (36878)
Australia (6006)
Bankruptcy (350)
Best Places to Work (11290)
Biosimilars (63)
Biotechnology (183)
C2C Services and Suppliers (78802)
California (1883)
Canada (934)
Cancer (491)
Career advice (1649)
Cell therapy (121)
China (150)
Clinical research (63276)
Collaboration (140)
Colorado (79)
Compensation (81)
Connecticut (74)
COVID-19 (2493)
Cystic fibrosis (73)
Data (312)
Diabetes (81)
Diagnostics (5975)
Drug pricing (63)
Earnings (83671)
Employer resources (142)
Europe (78757)
Events (107944)
Executive appointments (153)
FDA (16249)
Florida (265)
Funding (148)
Gene therapy (93)
GLP-1 (510)
Government (4290)
Healthcare (18629)
Hotbed/Location (481279)
Illinois (254)
Indiana (146)
Infectious disease (2522)
Inflammatory bowel disease (92)
Interviews (306)
IPO (16212)
Job creations (3627)
Job search strategy (1414)
Kansas (94)
Layoffs (393)
Legal (7832)
Lung cancer (110)
Manufacturing (86)
Maryland (397)
Massachusetts (1524)
Medical device (13048)
Medtech (13053)
Mergers & acquisitions (19029)
Metabolic disorders (247)
Michigan (124)
Minnesota (216)
Neuroscience (1291)
New Jersey (579)
New York (593)
NextGen Class of 2024 (6490)
Non-profit (4458)
North Carolina (591)
Northern California (824)
Obesity (146)
Ohio (104)
Opinion (171)
Patents (73)
Pennsylvania (581)
People (55916)
Pharmaceutical (60)
Phase I (19612)
Phase II (27874)
Phase III (20817)
Pipeline (112)
Postmarket research (2547)
Preclinical (8330)
Press Release (64)
Rare diseases (130)
Real estate (5895)
Recruiting (63)
Regulatory (21217)
Research institute (2305)
Resumes & cover letters (347)
South America (1085)
Southern California (761)
Startups (3566)
Texas (241)
United States (8567)
Vaccines (472)
Washington State (254)
Weight loss (127)
Date
Today (92)
Last 7 days (642)
Last 30 days (2450)
Last 365 days (37165)
2024 (26198)
2023 (40102)
2022 (51230)
2021 (55765)
2020 (54127)
2019 (46568)
2018 (35042)
2017 (32146)
2016 (31522)
2015 (37590)
2014 (31361)
2013 (26383)
2012 (28585)
2011 (29284)
2010 (27353)
679,671 Results for "latigo biotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Latigo Biotherapeutics Appoints Tim Lugo as Chief Financial Officer and Adds Beth Seidenberg and Jim Tananbaum to Board of Directors
September 9, 2024
·
6 min read
Biotech Beach
Latigo Biotherapeutics Debuts with $135 Million Series A Financing to Develop Non-Opioid Pain Medicines
Latigo Biotherapeutics Inc., a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target pain at its source, announced its emergence from stealth with a $135 million Series A financing.
February 14, 2024
·
3 min read
Press Releases
Latigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid Growth
July 22, 2024
·
3 min read
Press Releases
Latigo Biotherapeutics Announces Positive Phase 1 Data for Lead Non-Opioid Pain Medicine Candidate and Appoints Neil Singla, M.D., Chief Medical Officer
August 19, 2024
·
5 min read
Latigo Launches into Non-Opioid Pain Medicine Space with $135 Million Series A
Two weeks after Vertex’s Phase III data for VX-548 reenergized the field, Latigo Biotherapeutics announced $135 million in Series A funds to push its own NaV1.8 inhibitor into Phase II.
February 13, 2024
·
3 min read
·
Heather McKenzie
Business
Mid-Atlantic BioTherapeutics, Inc. and SMITM Capital Markets Ltd enter into a significant financing agreement
SMITM CAPITAL MARKETS LTD, has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage ready US biopharmaceutical company.
June 19, 2024
·
4 min read
Biotech Beach
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - June 07, 2024
Atara Biotherapeutics, Inc., a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, reported the grant of 9,700 restricted stock units of Atara’s common stock to one newly hired employee.
June 7, 2024
·
2 min read
Deals
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering
Calidi Biotherapeutics, Inc. today announced the pricing of its “reasonable best efforts” public offering of 15,197,500 shares of common stock (or pre-funded warrants in lieu thereof) and accompanying Series A Common Warrants.
April 16, 2024
·
5 min read
Biotech Beach
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
Calidi Biotherapeutics, Inc. announced the closing of its previously announced public offering of 15,197,500 shares of common stock and accompanying Series A Common Warrants, Series B Unit Warrants, with each unit consisting of one share of common stock and a Series B-1 Common Warrant and Series C Unit Warrants.
April 19, 2024
·
4 min read
Biotech Beach
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - April 05, 2024
Atara Biotherapeutics, Inc. reported the grant of 3,750 restricted stock units of Atara’s common stock to one newly hired employee.
April 5, 2024
·
2 min read
1 of 67,968
Next
